Most of the genetic analysis done today is performed on machines made by Illumina, the DNA sequencing giant.
Now a former director from the company is leading a startup that has raised $15 million to develop new genome sequencing tools.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,